Drug intelligence / Profile preview

amidephrine

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Intranasal
01

Overview

Amidephrine (also known as amidefrine) is a selective alpha1-adrenergic receptor agonist and sympathomimetic agent. It acts primarily as a vasoconstrictor and is used topically as a nasal decongestant for the treatment of allergic, acute, chronic, and vasomotor rhinitis. Amidephrine is structurally related to phenethylamines and is typically administered as its mesylate salt (amidephrine mesylate or amidefrine mesilate). Its main mechanism of action involves stimulation of alpha1-adrenoceptors in vascular smooth muscle, leading to vasoconstriction and reduced nasal congestion. As of 2000, it was marketed only in Austria[1][2][5].

Brand names
FentrinolDricolNalde
Other names
amidefrine3-methylsulfonamidyl-beta-hydroxy-N-methylphenethylamineamidefrine mesilateamidephrine mesylate
02

Targets

ADRA1A (α1A)

Beyond the preview

Go deeper on amidephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amidephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call